BATS | ETF
The fund generally uses a representative sampling strategy to achieve its investment objective, meaning it generally will invest in a sample of the securities in the index whose risk, return and other characteristics resemble the risk, return and other characteristics of the index as a whole.
The index is designed to provide exposure to equity securities of exchange listed companies globally that will be significantly transformed by advancements in genetics and biotechnology.
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| NTLA | Intellia Therapeutics Inc | Healthcare | Biotechnology | 5.31% |
| VERV | Verve Therapeutics Inc | Healthcare | Biotechnology | 5.08% |
| QURE | Uniqure NV | Healthcare | Biotechnology | 3.81% |
| CRSP | Crispr Therapeutics AG | Healthcare | Biotechnology | 3.29% |
| DNA | Ginkgo Bioworks Holdings | Healthcare | Biotechnology | 3.23% |
| STOK | Stoke Therapeutics Inc | Healthcare | Biotechnology | 2.53% |
| EDIT | Editas Medicine Inc | Healthcare | Biotechnology | 2.46% |
| SANA | Sana Biotechnology Inc | Healthcare | Biotechnology | 2.46% |
| BEAM | Beam Therapeutics Inc | Healthcare | Biotechnology | 2.26% |
| ARCT | Arcturus Therapeutics Holdings Inc | Healthcare | Biotechnology | 2.22% |
| RGNX | Regenxbio Inc | Healthcare | Biotechnology | 2.21% |
| NTRA | Natera Inc | Healthcare | Diagnostics & Research | 2.18% |
| AGIO | Agios Pharm | Healthcare | Biotechnology | 2.03% |
| UTHR | United Therapeutics Corporation | Healthcare | Drug Manufacturers - Specialty & Generic | 2.01% |
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 1.96% |
| NSIS-B | Novonesis (Novozymes) A/S | Basic Materials | Specialty Chemicals | 1.94% |
| IONS | Ionis Pharmaceuticals Inc | Healthcare | Biotechnology | 1.91% |
| TEM | Tempus AI, Inc. Class A Common Stock | Healthcare | Health Information Services | 1.88% |
| VCYT | Veracyte Inc | Healthcare | Diagnostics & Research | 1.79% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 1.63% |